About Renalytix AI plc (adapted from Renalytix AI plc prospectus):
They are an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs. Their ordinary shares trade on AIM, a market operated by the London Stock Exchange, under the symbol “RENX.”

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.